bioAffinity Technologies Files 2024 10-K
Ticker: BIAFW · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1712762
Sentiment: neutral
Topics: 10-K, annual-report, research
Related Tickers: BIAF
TL;DR
BIAF filed its 2024 10-K. Check financials and risks.
AI Summary
bioAffinity Technologies, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in San Antonio, TX, is involved in commercial physical and biological research. The filing details its financial position, business operations, and risk factors for investors.
Why It Matters
This filing provides a comprehensive overview of bioAffinity Technologies' financial health and strategic direction for the past fiscal year, crucial for investors assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a research-focused company, bioAffinity Technologies likely faces inherent risks related to product development, regulatory approvals, and market adoption.
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- San Antonio, TX (location) — Company headquarters
FAQ
What is the primary business of bioAffinity Technologies, Inc.?
bioAffinity Technologies, Inc. is engaged in Services-Commercial Physical & Biological Research, with SIC code 8731.
When did bioAffinity Technologies, Inc. file its 10-K report?
The 10-K report was filed on March 31, 2025.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Where is bioAffinity Technologies, Inc. located?
The company's business and mailing address is 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX 78217.
What is the SEC file number for bioAffinity Technologies, Inc.?
The SEC file number for bioAffinity Technologies, Inc. is 001-41463.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).